Superior activity of NKp44-CAR-T cells in comparison with ex vivo expanded activate NK cells or NKp30-CAR-T cells.
(2018)
Development of CAR-T therapy using NKp44 ectodomain for antigen recognition.
(2018)
Adoptive T cell immunotherapy against a wide range of malignancies by using chimeric antigen receptors with NK cell-like specificity (NKp44-CAR).
(2017)
A novel chimeric antigen receptor endows T cells with NK cell-like specificity and attacks a wide range of hematological malignancies and cancers.
(European Hematology Association 22nd Congress 2017)
2021/11 - academic award Development and characterisation of NKp44-based chimeric antigen receptors that confer T cells with NK cell-like specificity
2021 - academic encouragement award Development and characterisation of NKp44-based chimeric antigen receptors that confer T cells with NK cell-like specificity
2018/10 - 優秀演題賞 Development of CAR-T therapy using NKp44 ectodomain for antigen recognition
